Fortitude Family Office’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
PLC
MAM
RG
CWM
KL
YIH
MFG
GI
Fortitude Family Office's MXCT Position: Q2 2026 in Review
Fortitude Family Office opened a new position in MaxCyte (MXCT) in Q2 2026: 212 shares worth $261. The stake represents ﹤0.01% of the portfolio and ranks #2079 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in MXCT as recently as Q4 2025.
Fortitude Family Office first reported a position in MXCT in Q2 2025 and has held it in 3 quarters since. The position peaked at $2.85K in Q4 2025. 19 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Fortitude Family Office held 212 shares of MaxCyte worth $261 as of Q2 2026.
- MaxCyte was a new Fortitude Family Office position in Q2 2026.
- MaxCyte made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2079 holding.
- Fortitude Family Office first reported a position in MaxCyte in Q2 2025 and has held it in 3 quarters since.
- Fortitude Family Office's MaxCyte position peaked at $2.85K in Q4 2025.
- 19 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.